➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Express Scripts
Colorcon
AstraZeneca
Harvard Business School

Last Updated: July 14, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Thymopentin


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Thymopentin?

Thymopentin is an investigational drug.

There have been 8 clinical trials for Thymopentin. The most recent clinical trial was a Phase 3 trial.

The most common disease conditions in clinical trials are HIV Infections, Communicable Diseases, and Infection. The leading clinical trial sponsors are Immunobiology Research Institute, Fudan University, and [disabled in preview].

Recent Clinical Trials for Thymopentin
TitleSponsorPhase
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular CarcinomaFudan UniversityPhase 3
Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected PatientsImmunobiology Research InstituteN/A
A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected PatientsImmunobiology Research InstituteN/A

See all Thymopentin clinical trials

Clinical Trial Summary for Thymopentin

Top disease conditions for Thymopentin
Top clinical trial sponsors for Thymopentin

See all Thymopentin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Boehringer Ingelheim
Express Scripts
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.